Filing Details
- Accession Number:
- 0001477932-21-003660
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 20:01:27
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-27 20:01:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1643301 | Cure Pharmaceutical Holding Corp. | CURR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346171 | Nancy Duitch | 1620 Beacon Place Oxnard CA 93022 | Chief Strategy Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-25 | 1,000 | $0.70 | 5,020,869 | No | 4 | P | Indirect | By the Duitch Living Trust dated January 9, 1989 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By the Duitch Living Trust dated January 9, 1989 |
Footnotes
- This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.6950 to $0.7000. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 2 decimal points.